Concepedia

Publication | Closed Access

The Role of Force Control Agents in High-Dose Dry Powder Inhaler Formulations

DOI

87

Citations

27

References

2008

Year

Philippe Begat, David Morton, Jagdeep Shur, Paul Kippax, John N. Staniforth, Robert Price
Journal of Pharmaceutical Sciences

References

YearCitations

Handbook of Pharmaceutical Excipients

Flynn W. Warren

American Journal of Health-System Pharmacy

1987

3.3K

Large Porous Particles for Pulmonary Drug Delivery

David A. Edwards, Justin Hanes, Giovanni Caponetti,

Science

1997

1.2K

Dry powder inhaler formulation.

M Telko, Anthony J. Hickey

PubMed

2005

489

Formulation and Physical Characterization of Large Porous Particles for Inhalation

Rita Vanbever, Jeffrey D. Mintzes, Jue Wang,

Pharmaceutical Research

1999

312

(D) Routes of delivery: Case studies

John S. Patton, Robert M. Platz

Advanced Drug Delivery Reviews

1992

248

The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders

Lars‐Erik Briggner, Graham Buckton, Katarina Byström,

International Journal of Pharmaceutics

1994

216

The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations I: Direct Quantification by Atomic Force Microscopy

Philippe Begat, David Morton, John N. Staniforth,

Pharmaceutical Research

2004

213

Lactose and Lactase

Norman Kretchmer

Scientific American

1972

201

Dry powder formulations for pulmonary delivery

Richard Malcolmson, Jonathan K. Embleton

Pharmaceutical Science & Technology Today

1998

174

Alternative sugars as potential carriers for dry powder inhalations

Hartwig Steckel, Nina Bolzen

International Journal of Pharmaceutics

2003

171

Page 1